* The third axis would be continuous - intermittent (discontinuous).
The fourth could describe whether status appears de novo, in epileptics,
or in severely ill patients; the fifth axis could list whether status
epilepticus appears in wakefulness or different forms of sleep, particularly
slow wave sleep, or both [adapted from (Krumholz 1999)].
Table 4 Criteria for absence status epilepticus
• Prolonged change of consciousness or behavioral function (greater than
30 min)
• Generalized epileptic EEG abnormality (in classical cases 3/sec Spike-Slow
waves) that is definitively changed from the preictal state
• A prompt observable effect of IV antiepileptic drug on both ictal EEG
and clinical manifestations of the status
Adapted from (Porter and Penry 1983; Krumholz 1999)
In nonconvulsive status epilepticus, the level of consciousness may range
from a barely discernible (if any) decrease in level of consciousness
or alteration in cognition to comatose states in the face of severe anoxia.
The term “nonconvulsive status epilepticus” is very unsatisfactory because
the original use of it, which referred to "the wandering confused"
(Charcot patient) has now evolved to include the comatose, gravely ill
patient in the intensive care unit (Brenner 2002). Most of these patients
have myriad medical and metabolic problems.
Behavioral changes may be difficult to identify as being ictal in nature.
With nonconvulsive status epilepticus, effect and mood alteration may
vary widely, alternating between a state of delirium or mania-like episodes
with inappropriate laughter to depression. Patients will act strange or
have speech problems that range from the inappropriate “word salad” to
mutism. Echolalia-palilalia as the sole manifestation of nonconvulsive
status epilepticus (Linetsky 2000) and global developmental delay as the
main manifestation of nonconvulsive status epilepticus in a toddler (Shinawi
and Shahar 2001) have been recently described.
Differential diagnosis of the Landau-Kleffner syndrome should observe
several facts. In Landau-Kleffner syndrome there is a male preponderance
(about 2:1). Family history is usually negative, and children have previously
developed normally. The aphasia may develop in a subacute or gradual fashion
over weeks and, sometimes, over years. In some cases, the speech disorder
has been attributed to word deafness rather than aphasia. The course is
variable: Aphasia can fluctuate; complete remission might occur or progress
into mutism. Overt epileptic seizures are manifest in about 70% of cases
and are usually mild. According to the review of Beaumanoir, overt status
epilepticus of various types occurred in about 15% of cases (Beaumanoir
1985). The EEG is reported to consist of focal, multifocal, or generalized
high voltage spikes as well as spike-wave discharges with activation in
slow wave sleep evolving into nearly continuous electrographic status
("bioelectric status"). Since the EEG disturbances in Landau-Kleffner
syndrome usually involve the speech-dominant temporal region, it is not
surprising that a correlation between EEG abnormalities and language disorder
has been found (Shoumaker et al 1974; Cole et al 1988), although the temporal
relationship between electrical status epilepticus in sleep and the language
disturbance in Landau-Kleffner syndrome is loose in other cases (Paquier
et al 1992).
The similarities between Landau-Kleffner syndrome and epilepsy with continuous
spike-waves during slow wave sleep are obvious (Morikawa et al 1989).
Although the EEG changes are essentially generalized in continuous spike-waves
during slow wave sleep, some authors have included cases with relatively
focal abnormalities. In addition, in a study of spike-waves during slow
wave sleep using phase- and coherence-analysis, Kobayashi and colleagues
found that they were focal with secondary bilateral synchrony (or better
"synmorphy") (Kobayashi et al 1994). According to the review
of Morikawa and colleagues, continuous spike-waves during slow wave sleep
is present in 0.5% (of 12,854) children with epilepsy, and about 20% to
30% have identifiable brain pathology (eg, previous meningitis, birth
asphyxia, cytomegalovirus infection), 3% have a family history of epilepsy,
and 15% a history of febrile seizures (Morikawa et al 1989).
The concept that electrical status epilepticus in sleep may include a
large subset of developmental or acquired regressive conditions of infancy
is accepted (Tassinari et al 2000; Shinawi and Shahar 2001). Variations
among studies may be due to factors such as age of onset, the duration
of paroxysmal activity, its intensity, and its localization. Also, if
development has been distorted, subsequent progress is likely to be disturbed
after the primary condition has ceased to exist (Gordon 1997).
The typical core symptoms of electrical status epilepticus in sleep include
overt seizures, usually developing between the ages of 1 to 14 years (mean
about 5 years), and consisting of focal motor (tonic-clonic), absence-like,
atonic or complex partial, mental retardation (including impairment of
memory), deficiencies in temporal and spatial orientation, hyperkinetic
or aggressive behavior and psychosis, and striking abnormalities of speech
(Tassinari et al 1992). However, both Landau-Kleffner and electrical status
epilepticus in sleep occur at about the same age, are characterized by
striking abnormalities of speech, may have multiple seizure types, and
have severe EEG abnormalities in nonREM sleep.
At present, the nosological position of Landau-Kleffner syndrome and
electrical status epilepticus in sleep is not clear in regard to status.
As with the Lennox-Gastaut syndrome, they might represent epiphenomena
of specific encephalopathy. Some authors have emphasized that even benign
childhood epilepsy with centrotemporal spikes is not always benign, but
that a small proportion with the disorder evolve into "atypical benign
focal epilepsy of childhood," Landau-Kleffner syndrome, or epilepsy
with continuous spike-waves during slow wave sleep (Aicardi and Chevrie
1982; Kobayashi et al 1988; De Negri 1997; Fejerman et al 2000; Salanopoulou
et al 2000). For such boundary conditions, some French authors have used
the category "erratic" and have listed other rare manifestations
under this category. Acquired opercular syndrome (Veggiotti et al 1999)
could be listed here.
Although the Lennox-Gastaut syndrome also has features that overlap with
Landau-Kleffner syndrome and electrical status epilepticus in sleep, the
typical nocturnal electrical status epilepticus in sleep pattern is rare
in Lennox-Gastaut. The EEG pattern for Lennox-Gastaut is typically dominated
by polyspikes rather than spike waves; and tonic seizures, typical for
the Lennox-Gastaut syndrome, do not occur in typical cases of electrical
status epilepticus in sleep or Landau-Kleffner syndrome (Hirt 1996).
Partial status epilepticus with the expression of emotional/affective
and subtle vegetative-autonomous symptoms only. Status-like recurrent
pilomotor seizures are rare but well documented in relation to temporal
lobe pathology, usually gliomas (Andermann and Gloor 1984; Roze et al
2000). For many, the so-called interictal personality and behavioral syndrome
(Waxman and Geschwind 1975) as well as other described personality peculiarities
also are intimately linked with an active temporal lobe epilepsy (Wieser
and Landis 1983). Partial status epilepticus with the expression of emotional/affective
and subtle vegetative-autonomous symptoms exist (Wieser et al 1985). However,
the causal relationship usually remains a guess because very localized
ongoing epileptic discharges in deep brain regions cannot be picked up
in the routine scalp EEG. Pontius has reported on motiveless firesetting
and implicated partial limbic seizure kindling by revived memories of
fires in what she called "limbic psychotic trigger reaction"
(Pontius 1999).
Differentiating epileptic psychoses from psychomotor status epilepticus.
Epileptic behavioral disturbances and psychoses might be due to prolonged
nonconvulsive seizure activity. The idea that some abnormal mental states
in epilepsy might be a form of partial status epilepticus is intriguing.
Usually, epileptic psychosis is divided broadly into ictal, postictal,
and interictal categories, each with distinctive features (Trimble and
Bolwig 1992). Whereas the postictal psychosis is usually associated with
delirium, altered consciousness, and amnesia, the interictal psychosis
is characterized by clear consciousness, retained memory, and less severe
behavioral disturbances. The ictal psychosis in complex partial status
epilepticus with fluctuating or frequently recurring focal electrographic
epileptic discharges, arising in temporal or extratemporal regions, presents
itself as a confusional state with variable clinical state. It is said
that extratemporal, frontal focal status in particular has less cycling
symptomatology, and that severe confusion is less pronounced in comparison
to temporal lobe status epilepticus. Fronto-orbital polar status epilepticus
is said to be particularly poor in clinical symptoms.
In an attempt to re-examine interictal psychoses based on DSM IV Psychosis
Classification and International Epilepsy Classification, Kanemoto and
colleagues confirmed a close correlation between temporal lobe epilepsy
and interictal psychoses. Within the temporal lobe epilepsy group, early
epilepsy onset and a history of prolonged febrile convulsions were significantly
associated with interictal psychosis. Within the symptomatic localization-related
epilepsy group, complex partial seizures, autonomic aura, and temporal
EEG foci were closely associated with psychoses. There was also a significantly
higher incidence of ictal fear and secondary generalization in the group
with localization-related epilepsies with (as opposed to without) interictal
psychotic states (Kanemoto et al 2001).
Diagnostic workup
To diagnose nonconvulsive status epilepticus, 2 principal requirements
have to be fulfilled: (1) some clinically evident alteration in mental
status or behavior from baseline; and (2) seizure activity on the EEG.
There are many difficulties in defining baseline behavioral change, and
persons at risk for nonconvulsive status epilepticus are also those whose
behavioral changes might often be ascribed to other conditions. For example,
patients with mental retardation have clear cognitive abnormalities. Correlating
behavioral change from baseline with EEG evidence of ongoing epileptic
activity is essential to diagnose nonconvulsive status epilepticus.
Essential clinical features. The diagnosis of psychomotor or limbic
status epilepticus should be made only if clinical signs and symptoms,
typical or suggestive of, which last for more than 30 minutes, are accompanied
by clear-cut localized epileptiform discharge patterns including rhythmical
discharges in the corresponding brain region, which is most often the
temporal area. However, one has to consider that scalp EEG might miss
the ongoing discharges in deep limbic structures or reflect them incompletely
or distortedly. Clinical symptoms and signs are manifold (Gibbs and Stamps
1958; Engel 1989; Degen 1994) and can combine, although very often they
consist of plurimodal complex experiential hallucinations and twilight
states. A psychomotor status epilepticus requires video-documentation
of the behavior together with the EEG. Polygraphic recording of heart
rate, respiration, and galvanic skin reflex may be very useful.
EEG evidence of ictal activity. A wide spectrum of EEG ictal morphologies
may be seen with nonconvulsive status epilepticus (Kaplan 1999). Putting
aside EEG changes that have doubtful clinical significance such as midtemporal
theta of drowsiness, wicket spikes, or subclinical rhythmic epileptiform
discharges of adults, problems of interpretation may frequently be encountered
with rhythmic EEG morphologies that have sharp contours or waxing and
waning progressions.
Triphasic waves, when exceeding 1 per second and suppressed by diazepam,
very often straddle the borders of encephalopathy and epilepsy, particularly
when they exhibit spiky morphologies and wax and wane. Triphasic waves
are supposed to increase with arousal. Triphasic waves in lithium or other
acute intoxication may exhibit a prominent and distinctive first phase
resembling spike-slow-wave complexes; triphasic waves may decrease in
the setting of hyperammonemia after IV diazepam. Periodic or "pseudoperiodic"
lateralized epileptiform discharges pose a similar problem when associated
with neurologic deficits.
The EEG in psychomotor or limbic status epilepticus may exhibit localized
high-frequency tonic discharges restricted to limbic structures, along
with fast clonic, slow clonic, or mixed pattern (Wieser et al 1985) if
invasive intracranial EEG recording techniques such as depth electrodes,
foramen ovale electrodes, and subdural strips and grids are available.
Scalp EEG has its limitations and may not pick up localized discharges
in EEG of mesial temporal lobe structures. In the scalp EEG only propagated
and morphologically altered patterns might be seen. The scalp EEG discharges
most often consist of rhythmic theta or theta/delta (see also Table 1),
but other frequencies such as alpha (Bauer et al 2000) have also been
described in generalized nonconvulsive status epilepticus, which might
be viewed as a borderline form. In the 2 cases of Bauer and colleagues,
nonconvulsive status epilepticus (clinically and electroencephalographically)
started and ended abruptly (Bauer et al 2000). The ictal electroencephalographic
pattern was a monomorphic alpha activity with a generalized bilateral
distribution. Altered responsiveness, sometimes eyelid myoclonia (in 1
patient), and amnesia were the most characteristic clinical findings.
Waxing and waning as well as paroxysmal pattern changes can occur (Petsche
et al 1979; Wieser 1993). Waxing and waning may be seen in terms of time
(ie, appearance and disappearance of epileptiform patterns), but also
in terms of enlargement and diminution of the epileptogenic area (ie,
volume). Both phenomena might be interrelated and most probably are a
function of the specific properties of the neuronal population pathologically
recruited into the epileptiform discharges. Commonly, specific seizure
suppressing maneuvers exert a recognizable effect on the formal aspects
of the EEG discharges (Wieser 1980; Wieser and Hajek 1994).
Granner and Lee analyzed EEG characteristics comprehensively in a large
series (85 ictal episodes in 78 patients) of nonconvulsive status epilepticus
cases (Granner and Lee 1994). The ictal discharges were generalized in
59 episodes (69%), diffuse with focal predominance in 15 (18%), and focal
in 11 (13%). The morphologies and patterns of persistence varied greatly.
Frequency of ictal discharge was also variable and was almost always less
than 3 Hz. Several findings suggested possible focal onset with secondary
generalization even in so-called "generalized cases.” This study
confirmed that nonconvulsive status epilepticus is a highly heterogeneous
epileptic state electrographically.
Ictal SPECT may be very helpful for localizing the discharging
brain area and indeed can be easily accomplished in a status condition
(Mueller et al 2001).
1H-MRS and proton density- and diffusion-weighted MRI might show
changes associated with the discharging epileptic focus. Corresponding
to the clinical evolution, reversible and irreversible focally abnormal
metabolism can be determined with 1H-MRS, reflecting both increased neuronal
activity and neuronal damage (Flacke et al 2000; Lazeyras et al 2000;
Chu et al 2001).
Prolactin, luteinizing hormone, creatine-phosphokinase, neurone-specific
enolase, and indicators of adenosine triphosphate depletion. Concentrations
of prolactin and luteinizing hormone as well as creatine-phosphokinase
in blood were reported to show a good correlation with seizure frequency
(Leiderman et al 1990), and it has been suggested that an increase of
prolactin would be helpful for diagnosis of epileptic seizures, with a
view towards differentiating epileptic from nonepileptic events in particular.
Although prolactin concentrations exceeding 700 µU/mL might significantly
indicate an epileptic seizure (Bauer et al 1991), the absence of elevated
prolactin levels does not exclude status epilepticus (not even a grand-mal
status) and certainly not nonconvulsive partial status or absence status
(Tomson et al 1989; Kurlemann et al 1990; Fichsel 1991; 1994). Moreover,
prolactin was found to be elevated after nonepileptic seizures (Pohlmann
et al 1991). In addition, it should not be forgotten that endocrine and
neuroendocrine changes can occur as a result of antiepileptic drug therapy
(Lindbom et al 1992; Krause 1993), making a comparison with concentrations
of persons not treated with antiepileptic drugs rather difficult, even
if circadian fluctuations are taken into consideration. In conclusion,
prolactin and creatine-phosphokinase might be elevated after severe epileptic
seizures, but their value for differential diagnosis of epileptic versus
nonepileptic seizures is limited, and it is unlikely that they contribute
much to the diagnosis of nonconvulsive partial status.
DeGiorgio and colleagues and O'Regan and Brown found elevated neuron-specific
enolase, a marker of acute neuronal injury, in cerebrospinal fluid and
serum during complex partial and myoclonic nonconvulsive status epilepticus
(DeGiorgio et al 1996; 1999; O’Regan and Brown 1998). Livingston and colleagues
studied specific and sensitive indicators of neuronal adenosine triphosphate
depletion (hypoxanthine, xanthine, and uridine levels) in the cerebrospinal
fluid of 9 children during nonconvulsive status epilepticus (Livingston
et al 1989). These nucleotide metabolites were low during nonconvulsive
status epilepticus, but this was significant only for xanthine. The authors
speculatively link this reduction to a reduced neuronal protein synthesis,
which could lead to intellectual deterioration.
Response to treatment. In general, response to high-dosed antiepileptic
drug treatment can be used in the differential diagnosis, but there are
exceptions. We have encountered patients in whom classical antiepileptic
drugs of first choice, such as intravenous diazepam, did not completely
suppress the localized discharges associated with simple partial status
epilepticus (Wieser 1980). Intravenous diazepam may serve as a valuable
diagnostic tool in differentiating generalized from focal onset nonconvulsive
status epilepticus.
However, rhythmic sharp waves resulting from metabolic encephalopathy
can be abolished by benzodiazepines, similar to nonconvulsive status epilepticus,
without improvement in mental status (Fountain and Waldman 2001). Periodic
lateralized epileptiform discharges in severe vascular brain damage are
known to respond only moderately, if at all, to antiepileptic drug treatment.
Syndromes and diseases in
which the seizure type occurs
Nonconvulsive status epilepticus may be hidden or missed because the
behavioral change from baseline is ascribed to other causes including
intoxication, postictal states, cerebral ischemia, or psychiatric conditions
(Kaplan 1996).
In general, psychomotor status epilepticus is relatively rare. In a German
study of 100 patients with status epilepticus, 35% had nonconvulsive status
epilepticus, 33% had petit mal, and 2% had psychomotor (complex partial)
status epilepticus (Forster et al 1969). In a study of first seizures
in Minneapolis, 6 out of 125 patients having status epilepticus as a first
seizure event experienced nonconvulsive status epilepticus (Hauser 1980;
1983).
Nonconvulsive status epilepticus has been described in a wide variety
of diseases such as organ failure, electrolyte imbalance, peritoneal dialysis
(Chow et al 2001), hypersensitive encephalopathy, and epileptic encephalopathy
(Ruegg and Dichter 2003). It also has been reported in stroke (Afsar et
al 2003), with subarachnoid hemorrhage (Dennis et al 2002), malignant
tumor (Chang et al 2001), cortical dysplasia (Mueller et al 2001; Ng et
al 2003; Yoshimura 2003), the ring chromosome 20 syndrome (Petit 1999;
Augustijn et al 2001), pituitary apoplexy (Craig and Gibson 2000), Lafora
body disease (Corkill and Hardie 1999), multiple sclerosis (Maingueneau
et al 1999), hypocalcemia (Kline et al 1998) and after its treatment (Kumpfel
et al 2000), as well as in connection with HIV infection (Lechner et al
1998), as a complication of Mycoplasma pneumoniae infection (Jeffery et
al 1995), resulting from Jarisch-Herxheimer reaction in a patient with
neurosyphilis (Kojan et al 2000), with systemic lupus erythematosus (Fernandez-Torre
et al 2003), and in mentally retarded adults induced by recurrent rectal
diazepam overadministration (Brodtkorb et al 1993).
Medication and medication withdrawal have been repeatedly reported as
inducers of nonconvulsive status epilepticus (Delanty et al 1998). Examples
are microvascular endothelial cell chemotherapy of urothelial cancer (Meessen
et al 1990), cyclosporine treatment (Delpont et al 1990), ifosfamide (Primavera
et al 2002), cephalosporins (Dixit et al 2000; Martinez-Rodriguez et al
2002), and intrathecal fluorescein injection (Coeytaux et al 1999). Nonconvulsive
status epilepticus was described as a complication of electroconvulsive
therapy (Rao et al 1993; Solomons et al 1998; Szrich and Turbott 2000;
Parker et al 2001), and induced by various drugs, mainly psychotropic
agents (Yoshino 2000) such as antidepressants (Miyata et al 1997), neuroleptics,
ketamine (which has anticonvulsive and proconvulsive actions) (Kugler
and Doenicke 1994), morphine (Bertran et al 2000), and antiepileptics
such as tiagabine (Schapel and Chadwick 1996; Holtkamp et al 1999; Knake
et al 1999; Balslev et al 2000; Fitzek et al 2001; de Borchgrave et al
2003). In most instances tiagabine-induced nonconvulsive status epilepticus
is absence status (Knake et al 1999). Abrupt withdrawal of hypnotic-sedative
drugs, benzodiazepines in particular, may provoke nonconvulsive status
epilepticus (Emre et al 1985; Yoshino 2000). Nonconvulsive status epilepticus
has also been reported after replacement of valproate with lamotrigine
(Fernandez-Torre 2001; Trinka et al 2002).
Little is known on partial status epilepticus with the expression of
emotional/affective and subtle vegetative-autonomous symptoms only. Arroyo,
Cockerell and colleagues, and Rey and Papy have emphasized the "critical
confusional state of frontal origin in elderly” (Rey and Papy 1987; Cockerell
et al 1994; Arroyo 1997). Mewe and colleagues discussed the misdiagnosis
of nonconvulsive status epilepticus as posttraumatic exogenous psychosis
(Mewe et al 1989). Sailer and colleagues elaborated on the difficult question
of whether prodromal manifestations and episodic symptoms are nonspecific
complaints, or whether they represent nonconvulsive status epilepticus
(Sailer et al 1991).
Prognosis and complications
Sequelae associated with status epilepticus are best documented with
convulsive status epilepticus, but might also be associated with certain
types of nonconvulsive status epilepticus, particularly psychomotor (complex
partial) status epilepticus (Krumholz 1999).
There is increasing experimental as well as clinical evidence that generalized
convulsive status epilepticus produces lasting neuropathological damage
in the hippocampus, neocortex, and cerebellum due to associated metabolic
failure. Cerebellar (Purkinje and basket cell) damage was related particularly
to hyperpyrexia and hypotension, and was prevented by control of the systemic
metabolic derangements (ie, hyperpyrexia, hypotension, hypoxia, acidosis,
and hypoglycemia) (Meldrum et al 1973; DeGiorgio et al 1992).
Morbidity and mortality in relation to etiology. In contrast to
convulsive generalized status, various age dependent syndromes of status
epilepticus in neonates and children, and nonconvulsive status epilepticus
in the critically ill patient after acute brain injury, morbidity and
mortality is low in nonconvulsive status epilepticus. Nonconvulsive status
epilepticus has been thought of as a relatively benign entity because
it does not cause adverse systemic consequences of convulsive status epilepticus
(Meldrum et al 1973; Simon 1985). However, taken all cases of nonconvulsive
status epilepticus together (ie, including nonconvulsive status epilepticus
in the critically ill patient after acute brain injury as well as emergency
department studies), Treiman and colleagues found higher mortality rates
in nonconvulsive status epilepticus compared to generalized convulsive
epilepticus, 65% and 27% respectively (Treiman et al 1998).
Etiology is the main factor determining outcome. Other factors influencing
outcomes for both convulsive and nonconvulsive status epilepticus are
(1) duration, and (2) treatment of the status epilepticus, as well as
(3) age of the patient. Mortality and morbidity are lower in children
compared to adults: death (10% to 35%), intellectual and other neurologic
morbidity (10% to 35%), chronic epilepsy (30% of children first presenting
with status), and recurrent status epilepticus (15% to 20%) (Shinnar et
al 1992).
Nonconvulsive status epilepticus (and focal motor seizures) at onset
have been identified as risk factors for refractory convulsive status
epilepticus (Mayer et al 2002).
Absence status epilepticus appears to cause no lasting effects (Niedermeyer
and Khalife 1965; Andermann and Robb 1972; Thomas et al 1992; Gokyigit
and Caliskan 1995).
Since classical psychomotor status epilepticus usually occurs in patients
with known epilepsy, it is difficult to determine the risks and complications
of psychomotor status epilepticus itself. The theoretical basis for neuronal
injury resulting from psychomotor status epilepticus may be identical
to that from generalized convulsive. Although most reported cases of the
disorder have returned to baseline neurologic function (Mayeux and Lueders
1978; Cockerell et al 1994), several patients have had prolonged memory
deficits (Engel et al 1978; Treiman and Delgado-Escueta 1983). Recently
Varon and colleagues reported on a transient Kluver-Bucy syndrome following
complex partial status epilepticus (Varon et al 2003). Brett reported
22 cases of minor epileptic status involving children, differentiating
these cases from petit mal status by the presence of myoclonus and less
frequently occurring spike-wave patterns in the EEG (Brett 1966). These
status episodes lasted from days to months. Seizures preceded the onset
of these status episodes in 68%. At long-term follow up, 4 of these patients
had died, and only 6 patients (27%) remained intellectually normal. Degenerative
neurologic syndromes were identified in 14%.
Patients with electrographic status epilepticus in the setting of serious
medical illness have a terrible prognosis, but this is due mostly to serious
cerebrovascular or other medical illness. A patient will naturally worsen
if there is a progressive illness. In such patients, it is very difficult
to dissect out that portion of the long-term harm done by epileptiform
discharges or nonconvulsive status epilepticus (Privitera et al 1994;
Privitera and Strawsburg 1994; So et al 1995). The existing studies are
mainly pediatric and retrospective and are confounded by many variables
that are difficult to control such as medication, metabolic disturbances,
hypotension, and infection (Maytal et al 1989; Dodrill and Wilensky 1990;
Stores et al 1995). In general, when nonconvulsive status epilepticus
has been reported concurrent with acute brain injury, poor outcomes have
been attributed to the acute brain injury. Nonconvulsive status epilepticus
in such a constellation has been seen as an epiphenomenon, not necessarily
as a contributing cause of brain damage (Kaplan 1996; Aminoff 1998a).
However, recent evidence suggests, that nonconvulsive status epilepticus
might significantly increase the vulnerability of the brain to permanent
damage by mechanisms of secondary injury (Vespa et al 1999). Biochemical
evidence supports this deleterious synergy. DeGiorgio and colleagues found
the highest levels of serum neuronal enolase (a marker of neuronal injury)
in patient with combined status epilepticus and acute brain injury (DeGiorgio
et al 1995).
In summary, we conclude that discussion of permanent neurologic damage
from nonconvulsive status epilepticus in humans remains controversial
(Young and Jordan 1998; Aminoff 1998b; Drislane 1999). Taking into account
various subtypes of nonconvulsive status epilepticus, the picture becomes
clearer. For psychomotor (complex partial) status epilepticus several
studies indicate that prolonged memory deficits can occur (Engel et al
1978; Treiman and Delgado-Escueta 1983; Krumholz et al 1995).
Management
As discussed above, psychomotor (complex partial) status epilepticus
may induce long-term sequelae and might need more aggressive treatment
to prevent further brain damage. Today it is widely accepted that concurrent
acute brain injury and status epilepticus are synergistically deleterious
(Bogousslavski et al 1992; Waterhouse et al 1998; Jordan 1999). Waterhouse
and colleagues found that when status epilepticus complicates acute stroke,
mortality is 3 times higher than in stroke alone (Waterhouse et al 1998).
Therefore, for nonconvulsive status epilepticus in association with acute
brain injury, early and intensive intervention might be necessary (Jordan
1999). The danger that patients might suffer iatrogenically from aggressive
treatment makes it necessary to find a balance between the potential neurologic
morbidity of nonconvulsive status epilepticus and the possible morbidity
of intravenous antiepileptic drugs (Kaplan 1999). Hypotension and respiratory
depression are among the most common unwarranted side effects intravenous
antiepileptic drugs.
According to Shorvon, partial status epilepticus is reported to be controlled
by diazepam in 88% (of 67 patients) (Shorvon 1994). Therefore, for the
treatment of typical absence status epilepticus and uncomplicated complex
partial status epilepticus, oral benzodiazepines are recommended (Walker
2001).
Rapid-acting anesthetic agents, such as midazolam and propofol (Begemann
et al 2000), are being used more often for refractory status epilepticus,
though clinical trials are lacking (Chapman et al 2001; Hirsch and Claassen
2002). The role of propofol, which has barbiturate- and benzodiazepine-like
effects at the GABA-A receptor and has a potent anticonvulsant action
at clinical doses, has recently been reviewed by Stecker and colleagues
and Brown and Levin (Brown and Levin 1998; Stecker et al 1998).
Midazolam (MDZ) is considered an antiepileptic drug of first choice because
it is short acting and, therefore, can be well titrated on prolonged infusion.
The recommended regimen is for 1 or 2 bolus injections of 0.1 mg/kg to
0.3 mg/kg, to be followed by an infusion of 0.05 mg/kg to 0.4 mg/kg per
hour. After intravenous injection, midazolam is widely and rapidly distributed.
Distribution half-life is 15 minutes at physiological pH. The volume of
distribution is 0.6 l/kg to 1.7 l/kg and is higher in women, the obese,
and the elderly. Midazolam is 96% (range 94% to 98%) bound to plasma protein.
It is metabolized in the liver. At steady state, the blood concentration
of the metabolite (which has a shorter half-life than midazolam and contributes
little to the overall antiepileptic action) is about one third that of
the parent drug. Plasma clearance is 268 mL/minute to 630 mL/minute and
body clearance 5.8 mL/minute to 11.1 mL/minute per kg. The elimination
half life of 1.5 to 3.5 hours is prolonged to up to 10 hours in the elderly.
Chronic renal failure does not strongly affect pharmacokinetics. Severe
hepatic disease might, however, slow elimination. Usually mild bradycardia
and usually slight fall of arterial blood pressure may occur at conventional
doses. Apnea has not been reported in status, but this is clearly a potential
risk (Dundee et al 1984).
Several authors have reported on the usefulness of midazolam treatment
(Claasen et al.2001; Koul et al 2002; Fujikawa et al 2003). Claassen and
associates have studied the efficacy of continuous intravenous midazolam
for refractory nonconvulsive status epilepticus reviewing 33 episodes
of refractory nonconvulsive status epilepticus in their neurologic intensive
care unit over 6 years (Claassen et al 2001). All patients were monitored
with continuous EEG. Midazolam infusion rates were titrated to eliminate
clinical and EEG seizure activity; continuous intravenous midazolam was
discontinued once patients were seizure free for 24 hours. The mean duration
of status epilepticus before treatment was 3.9 days (range 0 to 17 days).
In addition to benzodiazepines, 94% of patients had received at least
2 antiepileptic drugs before starting continuous intravenous midazolam.
The mean loading dose was 0.19 mg/kg, the mean maximal infusion rate was
0.22 mg/kg/h, and the mean duration of continuous intravenous midazolam
therapy was 4.2 days (range 1 to 14 days). Acute treatment failure (seizures
1 to 6 hours after starting continuous intravenous midazolam) occurred
in 18% of episodes, breakthrough seizures (after 6 hours of therapy) in
56%, posttreatment seizures (within 48 hours of discontinuing therapy)
in 68%, and ultimate treatment failure (frequent seizures that led to
treatment with pentobarbital or propofol) in 18%. Breakthrough seizures
were clinically subtle or purely electrographic in 89% of cases and were
associated with an increased risk of developing posttreatment seizures.
The authors concluded that although most patients with refractory status
epilepticus initially responded to continuous intravenous midazolam, over
half developed subsequent breakthrough seizures, which were predictive
of posttreatment seizures and were often detectable only with continuous
EEG.
As mentioned above, the situation is different in those epileptiform
encephalopathies in which EEG spikes and sharp waves may not impair clinical
function but merely reflect damage from severe brain injuries. In disorders
such as anoxic encephalopathy or in some patients with periodic lateralized
epileptiform discharges very aggressive treatment is perhaps not indicated.
In periodic lateralized epileptiform discharges, increased mesiotemporal
lobe metabolism has been found in 1 patient, and this has been used as
an argument that periodic lateralized epileptiform discharges are manifestations
of partial status epilepticus (Handforth et al 1994). Abolition of sharp
waves by benzodiazepines might help to decide on treatment, but it is
known that rhythmic sharp waves resulting from metabolic encephalopathy
can be abolished by benzodiazepines, similar to nonconvulsive status epilepticus,
without improvement in mental status suggesting that definitive electrographic
diagnosis of primary nonconvulsive status epilepticus should not be based
entirely on abolition of sharp waves by benzodiazepines (Fountain and
Waldman 2001). Clearly, more work needs to be done regarding the significance
of certain EEG patterns (particularly periodic discharges) and when and
how to treat them (Hirsch and Claassen 2002).
References cited
Afsar N, Kaya D, Aktan S, Sykut-Bingol C. Stroke and status epilepticus:
stroke type, type of status epilepticus, and prognosis. Seizure 2003;12:23-7.
Aicardi J, Chevrie JJ. Atypical benign partial epilepsy of childhood.
Dev Med Child Neurol 1982;24: 281-92.
Ambrosetto G, Forti A, Spire JP, Tassinari CA. Studio elettroclinico
di due casi di stato di male epilettico parziale. In: Angeleri V, Canger
R. Progressi in epileptologia. Bull Italian League against Epilepsy, 1978;23:307-11.
Aminoff MJ. Do nonconvulsive seizures damage the brain - no. Controversies
in neurology. Arch Neurol 1998a;55:119-21.
Aminoff MJ. Management of status epilepticus. Can J Neurol Sci 1998b;25:4-6.
Andermann F, Gloor P. Pilomotor seizures. Neurology 1984;34:1623.
Andermann F, Lugaresi E, editors. Migraine and epilepsy. Boston, MA:
Butterworth, 1987.
Andermann F, Robb JP. Absence status: a reappraisal following review
of thirty-eight patients. Epilepsia 1972;13:177-87.
Arroyo S. Differential traits of non-convulsive status epilepticus. Neurologia
1997;12:31-7.
Augustijn PB, Parra J, Wouters CH, Joosten P, Lindhout D, van Emde Boas
W. Ring chromosome 20 epilepsy syndrome in children: electroclinical features.
Neurology 2001;57:1108-11.
Balslev T, Uldall P, Buchholt J. Provocation of non-convulsive status
epilepticus by tiagabine in three adolescent patients. Europ J Paed Neurology
2000;4:169-70.
Barry E, Sussmann NM, Bosley TM, et al. Ictal blindness and status epilepticus
amauroticus. Epilepsia 1985;26:577-84.
Bauer G. Psychische veränderungen bei kontinuierlichen epileptischen
entladungen. Schweiz Arch Neurol Neurochir Psychiat 1975;116:241-55.
Bauer J, Landgraf S, Schrell U, et al. Anstieg der serum-prolactinkonzentration
nach frontallappenanfällen. Dtsch Med Wschr 1991;16:1824-7.
Bauer J, Neumann M, Kolmel HW, Elger CE. Clinical correspondence: ictal
generalized rhythmic alpha activity during non-convulsive status epilepticus.
Eur J Neurol 2000;7:735-40.
Beaumanoir A. The Landau-Kleffner syndrome. In: Roger J, Dravet C, Bureau
M, Dreifuss FE, Wolf P, editors. Epileptic syndromes in infancy, childhood
and adolescence. London: John Libbey, 1985:181-91.
Begemann M, Rowan AJ, Tuhrim S. Treatment of refractory complex-partial
status epilepticus with propofol: case report. Epilepsia 2000;41:105-9.
Belafsky MA, Carwille S, Miller P, Waddell G, Boxley-Johnson J, Delgado-Esccueta
AV. Prolonged epileptic twilight states: continuous recordings with nasopharyngeal
electrodes and videotape analysis. Neurology 1978;28:239-45.
Ben-Ari Y, editor. The amygdaloid complex (INSERM symposium 20). Amsterdam:
Elsevier/North-Holland, Biomedical Press, 1981:516.
Bertram EH, Lenn NJ, Lothman EW. The hippocampus in experimental chronic
epilepsy: a morphometric analysis. Ann Neurol 1990;27:38-43.
Bertran F, Denise P, Letellier P. Nonconvulsive status epilepticus: the
role of morphine and its antagonist. Neurophysiol Clin 2000;30:109-12.
Bogousslavski J, Martin R, Regli F, Despland PA, Bolyn S. Persistent
worsening of stroke sequela after delayed seizures. Ann Neurol 1992;49:385-8.
Brenner RP. Is it status? Epilepsia 2002;43(Suppl 3):103-13.
Brett EM. Minor epileptic status. Dev Med Child Neurol 1966;24:80-1.
Bright R. Reports of medical cases, selected with a view of illustrating
the symptoms and cure of diseases by a reference to morbid anatomy. Vol
2. London: Taylor, 1831.
Brodtkorb E, Sand T, Kristiansen A, Torbergsen T. Non-convulsive status
epilepticus in the adult mentally retarded. Classification and role of
benzodiazepines. Seizure 1993;2:115-23.
Brody JA, Odom GL, Kunkle EC. Pilomotor seizures: report of a case associated
with a central glioma. Neurology 1960;10:993-7.
Brown LA, Levin GM. Role of propofol in refractory status epilepticus.
Ann Phamacother 1998;32:1053-9.
Calmeil LF. De l'épilepsie, étudiée sous le rapport de son siège et de
son influence sur la production de l'aliénation mentale. Paris: Thèse
de l'Université de Paris, 1824.
Cascino GD. Nonconvulsive status epilepticus in adults and children.
Epilepsia 1993;34(Suppl 1):21-8.
Celesia GG. EEG Monitoring in status epilepticus. In: Janz D, editor.
Epileptology. Stuttgart: Thieme, 1976:328-37.
Chang JW, Chang JH, Park SC, Kim TS, Park YG, Chung SS. Radiologically
confirmed de novo glioblastoma multiforme and hippocampal sclerosis associated
with the first onset of nonconvulsive simple partial status epilepticus.
Acta Neurochir (Wien) 2001;143:297-300; discussion 300-1.
Chapman MG, Smith M, Hirsch NP. Status epilepticus. Anaesthesia. 2001;56:648-59.
Charcot JM. Clinical lectures on the diseases of the nervous system.
Savill T, trans. London: New Sydenham Society, 1889.
Chatrian G, Shaw CM, Leffman H. The significance of periodic lateralized
epileptiform discharges. Electroencephalogr Clin Neurophysiol 1964;17:177-93.
Chatrian GE, Shaw CM, Luttrell CN. Focal electroencephalographic seizure
discharges in acute cerebral infarction. Neurology 1965;15:123-31.
Chow KM, Wang AY, Hui AC, Wong TY, Szeto CC, Li PK. Nonconvulsive status
epilepticus in peritoneal dialysis patients. Am J Kidney Dis 2001;38:400-5.
Christian W. Klinische elektroenzephalographie. Lehrbuch und atlas. 2.
Auflage. Stuttgart: Thieme, 1975.
Chu K, Kang DW, Kim JY, Chang KH, Lee SK. Diffusion-weighted magnetic
resonance imaging in nonconvulsive status epilepticus. Arch Neurol 2001;58:993-8.
Chung PW, Seo DW, Kwon JC, Kim H, Na DL. Nonconvulsive status epilepticus
presenting as a subacute progressive aphasia. Seizure 2002;11:449-54.
Claassen J, Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA. Continuous
EEG monitoring and midazolam infusion for refractory nonconvulsive status
epilepticus. Neurology 2001;57:1036-42.
Clark LP, Prout TP. Status epilepticus: a clinical and pathological study
in epilepsy (an article in 3 parts). Am J Insanity 1903/4;60:291-306.
Cockerell OC, Walker MC, Sander JW, Shorvon SD. Complex partial status
epilepticus: a recurrent problem. J Neurol Neurosurg Psychiatry 1994;57:835-7.
Coeytaux A, Reverdin A, Jallon P, Nahory A. Non convulsive status epilepticus
following intrathecal fluorescein injection. Acta Neurol Scand 1999;100:278-80.
Cole AJ, Andermann F, Taylor L, et al. The Landau-Kleffner syndrome of
acquired epileptic aphasia: unusual clinical outcome, surgical experience,
and absence of encephalitis. Neurology 1988;38:31-8.
Commission on Classification and Terminology of the International League
Against Epilepsy: Proposal for revised classification of epileptic seizures.
Epilepsia 1981;22:489-501.
Commission on Classification and Terminology of the International League
Against Epilepsy: Proposal for revised classification of epilepsies and
epileptic syndromes. Epilepsia 1989;30:389-99.
Corkill RG, Hardie RJ. An unusual case of Lafora body disease. Eur J
Neurol 1999;6:245-7.
Coulter DA, DeLorenzo RJ. Basic mechanisms of status epilepticus. Adv
Neurol 1999;79:725-33.
Craig JJ, Gibson JM. Non-convulsive status epilepticus: a treatable cause
of confusion in pituitary apoplexy. Br J Neurosurg 2000;14:141-3.
de Borchgrave V, Lienard F, Willemart T, van Rijckevorsel K. Clinical
and EEG findings in six patients with altered mental status receiving
tiagabine therapy. Epilepsy Behav 2003;4:326-37.
Degen R. Besondere manifestationen epileptischer anfälle. In: Fröscher
W, Vassella F, editors. Die epilepsien. Berlin: W de Gruyter, 1994:475-86.
DeGiorgio CM, Correale J, Gott PS, et al. Serum neuron specific enolase
in human status epilepticus. Neurology 1995;45:1134-7.
DeGiorgio CM, Gott PS, Rabinowicz AL, Heck CN, Smith T, Correale J. Neuron-specific
enolase, a marker of acute neuronal injury, is increased in complex partial
status epilepticus. Epilepsia 1996;37:606-9.
DeGiorgio CM, Heck CN, Rabinowicz AL, Gott PS, Smith T, Correale J. Serum
neuron-specific enolase in the major subtypes of status epilepticus. Neurology
1999;52:746-9.
DeGiorgio CM, Tomiyasu U, Gott PS, Treiman DM. Hippocampal pyramidal
cell loss in human status epilepticus. Epilepsia 1992;33:23-7.
Delanty N, Vaughan CJ, French JA. Medical causes of seizures. Lancet
1998;352:383-90.
Delgado-Escueta AV, Wasterlain CG, Treimann DM, Porter RJ, editors. Status
epilepticus. Advances in neurology. Vol. 34. New York: Raven Press, 1983:15-35.
Delpont E, Thomas P, Gugenheim J, et al. Prolonged confusion syndrome
in the course of cyclosporine treatment: a state of confusion? Neurophysiol
Clin 1990;20:207-15.
De Negri M. Electrical status epilepticus during sleep (ESES). Different
clinical syndromes: towards a unifying view? Brain Dev 1997;19:447-51.
Dennis LJ, Claassen J, Hirsch LJ, Emerson RG, Connolly ES, Mayer SA.
Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurgery
2002;51:1136-43; discussion 1144.
Deonna TW. Acquired epileptiform aphasia in children (Landau-Kleffner
syndrome). J Clin Neurophysiol 1991;8:288-98.
Dixit S, Kurle P, Buyan-Dent L, Sheth RD. Status epilepticus associated
with cefepime. Neurology 2000;54:2153-5.
Dodrill CB, Wilensky AJ. Intellectual impairment as an outcome of status
epilepticus. Neurology 1990;40(Suppl 2):23-7.
Dreyer R. Zur frage des status epilepticus mit psychomotorischen anfällen.
Ein beitrag zum temporalen status epilepticus und zu atypischen dämmerzuständen
und verstimmungen. Nervenarzt 1965;36:221-3.
Dreyer R, Wehmeyer W. Status mit psychomotorischen Anfällen. Beitrag
zur klinischen und hirnelektrischen Problematik. Nervenarzt 1977;48:612-30.
Drislane FW. Evidence against permanent neurologic damage from nonconvulsive
status epilepticus. J Clin Neurophysiol 1999;16:323-31.
Drislane FW. Presentation, evaluation, and treatment of nonconvulsive
status epilepticus. Epilepsy Behav 2000;1:301-14.
Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam: a review of
its pharmacological properties and therapeutic use. Drugs 1984;28:519-43.
Emre M, Walser H, Baumgartner G. Non-convulsive status epilepticus after
abrupt withdrawal of hypnotic-sedative drugs. Eur Arch Psychiatry Neurol
Sci 1985;235:21-5.
Engel J Jr. Seizures and epilepsy. Contemporary neurology series. Vol.
31. Philadelphia: FA Davis Company, 1989.
Engel J Jr, Ludwig BJ, Feteli M. Prolonged partial complex status epilepticus:
EEG and behavioral observations. Neurology 1978;28:863-9.
Escueta AV, Boxley J, Stubbs N, Waddell G, Wilson WA. Prolonged twilight
state and automatisms: a case report. Neurology 1974;24:331-9.
Fejerman N, Caraballo R, Tenembaum SN. Atypical evolutions of benign
localization-related epilepsies in children: are they predictable? Epilepsia
2000;41:380-90.
Fernandez-Torre JL. De novo absence status of late onset following withdrawal
of lorazepam: a case report. Seizure 2001;10:433-7.
Fernandez-Torre JL, Sanchez JM, Gonzalez C, Fernandez-Guinea O. Complex
partial status epilepticus of extratemporal origin in a patient with systemic
lupus erythematosus. Seizure 2003;12:245-8.
Fichsel H. Labordiagnostik zur therapieüberwachung und zur anfallsdiagnostik.
In: Fröscher W, Vassella F, editors. Aspekte der epilepsie-diagnostik.
Berlin: Blackwell Wissenschaft, 1991:24-36.
Fichsel H. Spezielle laboruntersuchungen zur anfallsdiagnostik: CPK,
prolaktin. In: Fröscher W, Vasella F, editors. Die epilepsien. Berlin:
W de Gruyter, 1994:439-40.
Fitzek S, Hegemann S, Sauner D, Bonsch D, Fitzek C. Drug-induced nonconvulsive
status epilepticus with low dose of tiagabine. Epileptic Disord 2001;3:147-50.
Flacke S, Wullner U, Keller E, Hamzei F, Urbach H. Reversible changes
in echo planar perfusion- and diffusion-weighted MRI in status epilepticus.
Neuroradiology 2000;42:92-5.
Forster C, Ross A, Kugler J. Psychomotor status epilepticus. Electroencephalogr
Clin Neurophysiol 1969;27:211.
Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J Clin
Neurophysiol 1995;12:326-42.
Fountain NB, Waldman WA. Effects of benzodiazepines on triphasic waves:
implications for nonconvulsive status epilepticus. J Clin Neurophysiol
2001;18:345-52.
Fromm GH, Faingold C, Browning RA, Burnham WM, editors. Epilepsy and
the reticular formation. Neurology and neurobiology. Vol. 27. New York:
Alan R Liss Inc, 1987.
Fujikawa Y, Sugai K, Hanaoka S, Fukumizu M, Sasaki M, Kaga M. Three cases
with severe motor and intellectual disabilities presenting the severest
condition caused by prolonged non-convulsive status epilepticus. [Article
in Japanese] No To Hattatsu 2003;35:43-8.
Gaggero R, Caputo M, Fiorio P, et al. SPECT and epilepsy with continuous
spike waves durino slow wave sleep. Childs Nerv Syst 1995;11:154-60.
Gastaut H. Clinical and electroencephalographical classification of epileptic
seizures. Epilepsia 1969;10(Suppl):2-13.
Gastaut H. Clinical and electroencephalographical classification of epileptic
seizures. Epilepsia 1970;11:102-13.
Gastaut H. Dictionary of epilepsy. Geneva: World Health Organization,
1973.
Gastaut H. Classification of status epilepticus. In: Delgado-Escueta
AV, Wasterlain CG, Treimann DM, Porter RJ, editors. Status epilepticus.
Advances in neurology. Vol. 34. New York: Raven Press, 1983:15-35.
Gastaut H, Roger J, Lob H, editors. Les états de mal épileptique: compte
rendu de la réunion européenne d'information électroencephalographique,
Xth Colloque de Marseille 1962. Paris: Masson, 1967.
Gastaut H, Roger J, Roger A. Sur la signification de certaines fugues
épileptiques. A propos d'une observation électroclinique d’état de mal
temporal Rev Neurol 1956;94:298-301.
Gastaut H, Tassinari C. Status epilepticus. In: Remond A, editor. Handbook
of electroencephalography and clinical neurophysiology. Vol 13A. Amsterdam:
Elsevier, 1975:39-45.
Gerstle de Pasquet E, Silva Gaudin E, Bianchi A, Mendilaharsu SA. Prolonged
and monosymptomatic dysphasic status epilepticus. Neurology 1976;26:244-7.
Gibbs FA, Stamps FW. Epilepsy handbook. Springfield: Thomas, 1958.
Girgis M, Kiloh LG, editors. Limbic epilepsy and the dyscontrol syndrome.
Developments in Psychiatry. Vol. 4. Amsterdam: Elsevier/North-Holland
Biomed Press, 1980.
Gokyigit A, Caliskan A. Diffuse spike-wave status of 9-year duration
without behavioural change or intellectual decline. Epilepsia 1995;36:210-3.
Gordon N. The Landau-Kleffner syndrome: increased understanding. Brain
Dev 1997;19:311-6.
Gorter JA, Goncalves Pereira PM, van Vliet EA, Aronica E, Lopes da Silva
FH, Lucassen PJ. Neuronal cell death in a rat model for mesial temporal
lobe epilepsy is induced by the initial status epilepticus and not by
later repeated spontaneous seizures. Epilepsia. 2003;44:647-58.
Granner MA, Lee SI. Nonconvulsive status epilepticus: EEG analysis in
a large series. Epilepsia 1994;35:42-7.
Green JB. Pilomotor seizures. Neurology 1984;34:837-9.
Handforth A, Cheng JT, Mandelkern MA, Treiman DM. Markedly increased
mesiotemporal lobe metabolism in a case with PLEDs: further evidence that
PLEDs are manifestations of partial status epilepticus. Epilepsia 1994;35:876-81.
Hauser WA. Epidemiology, morbidity and mortality of status epilepticus.
Presented at the International Symposium on Status Epilepticus. Santa
Monica, California: 1980.
Hauser WA. Status epilepticus: Frequency, etiology and neurological sequelae.
In: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ, editors.
Status epilepticus. Advances in neurology. Vol 34. New York: Raven Press,
1983:3-14.
Hedenstrom I, Schorsch G. EEG-befunde bei epileptischen dämmer- und verstimmungszuständen.
Arch Psychiat Nervenkr 1959;199:311-29.
Heintel H. Status von tonischen dämmerattacken. Arch Psychiat Nervenkr
1969;21:117-25.
Henke K, Buck A, Weber B, Wieser HG. Human hippocampus establishes associations
in memory. Hippocampus 1997;7:249-56.
Henke K, Weber B, Kneifel S, Wieser HG, Buck A. Human hippocampus associates
information in memory. Proc Nat Acad Sci U S A 1999b;96:5884-9.
Henke K, Weber B, Schwedler K, et al. PET studies of memory. Schweiz
Arch Neurol Psych 1999a;150:89-96.
Henriksen GF. Status epilepticus partialis with fear as clinical expression.
Report of a case and ictal EEG-findings. Epilepsia 1973;14:39-46.
Hess R, Scollo-Lavizzari G, Wyss FE. Borderline cases of petit mal status.
Eur Neurol 1971;5:137-54.
Hilkens PH, de Weerd AW. Non-convulsive status epilepticus as cause for
focal neurological deficit. Acta Neurol Scand 1995;92:193-7.
Hirsch LJ, Claassen J. The current state of treatment of status epilepticus.
Curr Neurol Neurosci Rep 2002;2:345-56.
Hirt HR. Nosology of Lennox-Gastaut syndrome. Nervenarzt 1996;67:109-22.
Holtkamp M, Pfeiffer M, Buchheim K, Meierkord H. Tiagabine and non-convulsive
status epilepticus. Nervenarzt 1999;70:1104-6.
Hosford DA. Animal models of nonconvulsive status epilepticus. J Clin
Neurophysiol 1999;16:306-13.
Isler HR, Wieser HG, Egli M. Hemicrania epileptica. In: Rose FC, editors.
Progress in migraine research 2. London: Pitman Books, 1984:69-82.
Jagoda A. Nonconvulsive seizures. Emerg Med Clin North Am 1994;12:963-71.
Janz D. Die Epilepsien. Stuttgart: Thieme, 1969.
Jeffery KJ, Ellis SJ, Fink CG. Non-convulsive status epilepticus as a
complication of Mycoplasma pneumoniae infection. Br J Clin Pract 1995;49:155-6.
Jordan KG. Nonconvulsive status epilepticus in acute brain injury. J
Clin Neurophysiol 1999;16:306-13.
Kanemoto K, Tsuji T, Kawasaki J. Reexamination of interictal psychoses
based on DSM IV Psychosis Classification and International Epilepsy Classification.
Epilepsia 2001;42:98-103.
Kaplan PW. Nonconvulsive status epilepticus in the emergency room. Epilepsia
1996;37:643-50.
Kaplan PW, editor. Nonconvulsive status epilepticus. J Clin Neurophysiol
1999;16:323-60.
Kaplan PW. Behavioral manifestations of nonconvulsive status epilepticus.
Epilepsy Behav 2002;3:122-39.
Karbowski K. Status psychomotoricus. Klinische und elektroenzephalographische
aspekte. In: Karbowski K, editor. Status psychomotoricus und seine differentialdiagnose.
Bern: Hans Huber, 1980:39-71.
Khan N, Wieser HG. Limbic encephalitis: a case report. Epilepsy Res 1994;17:175-81.
Kline CA, Esekogwu VI, Henderson SO, Newton KI. Non-convulsive status
epilepticus in a patient with hypocalcemia. J Emerg Med 1998;16:715-8.
Knake S, Hamer HM, Schomburg U, Oertel WH, Rosenow F. Tiagabine-induced
absence status in idiopathic generalized epilepsy. Seizure 1999;8:314-7.
Kobayashi K, Murakimi N, Yoshinaga H, Enoki H, Ohtsuka Y, Ohtahara S.
Nonconvulsive status epilepticus with continuous diffuse spike and wave
discharges during sleep in childhood. Jpn J Psychiatry Neurol 1988;42:509-14.
Kobayashi K, Nishibayashi N, Ohtsuka Y, Oka E, Ohtahara S. Epilepsy with
electrical status epilepticus during slow sleep and secondary bilateral
synchrony. Epilepsia 1994;35:1097-103.
Kojan S, Van Ness PC, Diaz-Arrastia R. Nonconvulsive status epilepticus
resulting from Jarisch-Herxheimer reaction in a patient with neurosyphilis.
Clin Electroencephalogr 2000;31:138-40.
Koul R, Chacko A, Javed H, Al Riyami K. Eight-year study of childhood
status epilepticus: midazolam infusion in management and outcome. J Child
Neurol. 2002;17:908-10.
Krause KH. Nebenwirkungen der antiepileptika. In: Fröscher W, Vasella
F, editors. Die Epilepsien. Berlin: W de Gruyter, 1993:660-98.
Kroth H, Hopf HC. Status psychomotorischer anfälle. Dtsch Z Nervenheilk
1966;189:67-78.
Krsek P, Mikulecka A, Druga R, Hlinak Z, Kubova H, Mares P. An animal
model of nonconvulsive status epilepticus: a contribution to clinical
controversies. Epilepsia 2001;42:171-80.
Krumholz A. Epidemiology and evidence for morbidity of nonconvulsive
status epilepticus. J Clin Neurophysiol 1999;16:314-22.
Krumholz A, Sung G, Fisher RS, Barry E, Bergey GK, Grattan LM. Complex
partial status epilepticus accompanied by serious morbidity and mortality.
Neurology 1995;45:1499-504.
Kugler J, Doenicke A. Ketamine-anticonvulsive and proconvulsive actions.
Anaesthesist 1994;43(Suppl 2):2-7.
Kumpfel T, Lechner C, Auer D, Kraft E, Lydtin H, Trenkwalder C. Non-convulsive
status epilepticus with marked neuropsychiatric manifestations and MRI
changes after treatment of hypercalcaemia. Acta Neurol Scand 2000;102:337-9.
Kurlemann G, Heyen P, Menges EM, et al. Prolaktin und wachstumshormon
im serum nach zerebralen Krampfanfällen im kindes- und jugendalter. Epilepsie-Blätter
1990;3(Suppl):16.
Landau WM. Landau-Kleffner syndrome: an eponymic badge of ignorance.
Arch Neurol 1992;49:353-9.
Landau WM, Kleffner F. Syndrome of acquired aphasia with convulsive disorder
in children. Neurology 1957;7:523-30.
Landolt H. Die temporallappen-epilepsie und ihre psychopathologie. Psychiat
Neurol Basel 1960;(Suppl1)12:1-102.
Landolt H. Die dämmer- und verstimmungszustände bei epilepsie und ihre
elektroenzephalographie. Z Gesamte Inn Med 1963;185:411-30.
Lazeyras F, Blanke O, Zimine I, Delavelle J, Perrig SH, Seeck M. MRI,
(1)H-MRS, and functional MRI during and after prolonged nonconvulsive
seizure activity. Neurology 2000;55:1677-82.
Lechner C, Auer D, Kumpfel T, Hesse J, Fuchs HH. Prolonged non-convulsive
status epilepticus as an early clinical manifestation of epilepsy in connection
with HIV infection-case report with EEG and MRI follow-up. Fortschr Neurol
Psychiatr 1998;66:326-30.
Leiderman DB, Csernansky JG, Moses JA. Neuroendocrinology and limbic
epilepsy: relationships to psychopathology, seizure variables, and neuropsychological
function. Epilepsia 1990;31:270-4.
Lennox WG. The petit mal epilepsies - their treatment with tridione.
JAMA 1945;129:1069-74.
Lennox WG, Lennox MA. Epilepsy and related disorders. Boston/Toronto:
Little, Brown Comp, 1960.
Le Van Quyen M, Adam C, Boulac M, Martinerie J, Varela FJ. Nonlinear
interdependencies of EEG signals in human intracranially recorded temporal
lobe seizures. Brain Res 1998;792:24-40.
Le Van Quyen M, Martinerie J, Adam C, Varela FJ. Nonlinear analyses of
interictal EEG map the brain interdependeces in human focal epilepsy.
Physica D 1999;127:250-66.
Le Van Quyen M, Martinerie J, Navarro V, et al. Anticipation of epileptic
seizures from standard EEG recordings. Lancet 2001;357:183-8.
Licht EA, Fujikawa DG. Nonconvulsive status epilepticus with frontal
features: quantitating severity of subclinical epileptiform discharges
provides a marker for treatment efficacy, recurrence and outcome. Epilepsy
Res 2002;51:13-21.
Lindbom U, Tomson T, Nilsson BY, Andersson DE. Serum prolactin response
to metoclopramide during status epilepticus. J Neurol Neurosurg Psychiatry
1992;55:685-867.
Linetsky E, Planer D, Ben-Hur T. Echolalia-palilalia as the sole manifestation
of nonconvulsive status epilepticus. Neurology 2000;55:733-4.
Livingston JH, Brown JK, Harkness RA, McCreanor GM. Cerebrospinal fluid
nucleotide metabolites following non-convulsive status epilepticus. Dev
Med Child Neurol 1989;31:168-73.
Livingston KE, Escobar A. Anatomical bias of the limbic system concept.
A proposed reorientation. Arch Neurol 1971;24:17-21.
Lothman EW, Bertram EH, Bekenstein JW, Perlin JB. Self-sustaining limbic
status epilepticus induced by "continuous" hippocampal stimulation:
electrographic and behavioral characteristics. Epilepsy Res 1989;3:107-19.
Lou HC, Brandt S, Bruhn P. Aphasia and epilepsy in childhood. Acta Neurol
Scand 1977;56:46-54.
Lowenstein DH, Shimosaka S, So YT, Simon RP. The relationship between
electrographic seizure activity and neuronal injury. Epilepsy Res 1991;10:49-54.
Lugaresi E, Pazzaglia P, Tassinari CA. Differentiation of absence status
and temporal lobe status. Epilepsia 1971;12:77-87.
Macdonald RL, editor. Status epilepticus in adults and children: new
developments in pathogenesis and treatment. Epilepsia 1999;40(Suppl 1):1-66.
Maingueneau F, Honnorat J, Isnard J, et al. Partial non-convulsive status
epilepsy in multiple sclerosis. Neurophysiol Clin 1999;29:463-72.
Maquet P, Hirsch E, Metz-Lutz MN, et al. Regional cerebral glucose metabolism
in children with deterioration of one or more cognitive functions and
continuous spike-and-wave discharges during sleep. Brain 1995;118:1497-520.
Markand ON, Wheeler GL, Pollack SL. Complex partial status epilepticus
(psychomotor status). Neurology 1978;28:189-96.
Martinez-Rodriguez JE, Barriga FJ, Santamaria J, et al. Nonconvulsive
status epilepticus associated with cephalosporins in patients with renal
failure. Am J Med 2001;111:115-9. Comment in: Am J Med 2002;15:112:243-5.
Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF.
Refractory status epilepticus: frequency, risk factors, and impact on
outcome. Arch Neurol 2002;59:205-10.
Mayeux R, Lueders H. Complex partial status epilepticus: case report
and proposal for diagnostic criteria. Neurology 1978;28:957-61.
Maytal J, Shinnars S, Moshe SL, Alvarez LA. Low morbidity and mortality
of status epilepticus in children. Pediatrics 1989;83:323-31.
McLachlan RS, Blume WT. Isolated fear and complex partial status epilepticus.
Ann Neurol 1980;8:639-41.
Meessen S, Riedel RR, Bruhl P. Status epilepticus in MVEC chemotherapy
of urothelial cancer. Urologe A 1990;29:348-9.
Meldrum BS, Vigouroux RA, Brierley JB. Systemic factors and epileptic
brain damage. Arch Neurol 1973; 29:82-7.
Mewe R, Konig HJ, Elger CE, Wieser HG. Verkennung nicht-konvulsiver staten
als posttraumatische exogene Psychose. Nervenarzt 1989;60:433-6.
Miyata H, Kubota F, Shibata N, Kifune A. Non-convulsive status epilepticus
induced by antidepressants. Seizure 1997;6:405-7.
Morikawa T, Seino M, Watanabe Y, Watanabe M, Yagi K. Clinical relevance
of continuous spike-waves during slow waves sleep. In: Manelis J, Bental
E, Loeber JN, Dreifuss FE, editors. The Eighth Epilepsy International
Symposium. New York: Raven Press, 1989:359-63.
Morrell F, Whisler WW, Smith MC, et al. Landau-Kleffner syndrome. Treatment
with subpial intracortical transection. Brain 1995;118:1529-46.
Moser HR, Meier PF, Wieser HG, Weber B. Pre-ictal changes and EEG analyses
within the framework of Lyapunov theory. In: Lehnertz K, Arnhold J, Grassberger
P, Elger CE, editors. Chaos in brain? Singapore: World Scientific, 2000:96-111.
Mueller D, Mueller J. Lachen als epileptische manifestation. VEB G. Jena:
Fischer, 1980.
Mueller SG, Trabesinger AH, Buck F, Kollias SS, Boesiger P, Wieser HG.
Proton magnetic resonance spectroscopy characteristics of a focal cortical
dysgenesis during status epilepticus and in the interictal state. Seizure
2001;10(7):518-24.
Murchison JT, Sellar RJ, Steers AJ. Status epilepticus presenting as
progressive dysphasia. Neuroradiology 1995;37:438-9.
Niedermeyer E. Epileptic seizure disorders. In: Niedermeyer E, Lopes
da Silva F, editors. Electroencephalography. 3rd ed. Baltimore: Williams
and Wilkins, 1993:461-564.
Niedermeyer E, Khalifeh R. Petit mal status ("spike-wave-stupor"):
an electro-clinical appraisal. Epilepsia 1965;6:250-62.
Nowack WJ, Shaikh IA. Progression of electroclinical changes in complex
partial status epilepticus: filling in the blanks. Clin Electroenephalogr
1999;30:5-8.
Oller Daurella L, Oller Ferrer-Vidal L, Russi A, Conill J. Los estados
de mal de crisis parciales complejas. In: Angeleri V, Canger R, editors.
Progressi in epileptologia. Bull Italian League against Epilepsy 1978;23:209-11.
Olney JW, de Gubareff T, Sloviter RS. "Epileptic" brain damage
in rats induced by sustained electrical stimulation of the perforant path.
II. Ultrastructural analysis of acute hippocampal pathology. Brain Res
Bull 1983;10:699-712.
O'Regan ME, Brown JK. Serum neuron specific enolase: a marker for neuronal
dysfunction in children with continuous EEG epileptiform activity. Eur
J Paediatr Neurol 1998;2:193-7.
Otero E, Cordova S, Diaz F, Garcia-Teruel I, Del-Brutto OH. Acquired
epileptic aphasia (the Landau-Kleffner syndrome) due to neurocysticercosis.
Epilepsia 1989;30:569-72.
Paetau R, Granstrom ML, Blomstedt G, Jousmaki V, Korkman M, Liukkonen
E. Magnetoencephalography in presurgical evaluation of children with the
Landau-Kleffner syndrome. Epilepsia 1999;40:326-35.
Paetau R, Kajola M, Korkman M, Hamalainen M, Granstrom ML, Hari R. Landau-Kleffner
syndrome: epileptic activity in the auditory cortex. Neuroreport 1991;2:201-4.
Palem RM, Force L, Esvan J. Hallucinations critiques épileptiques et
délire. Ann Med Psychol (Paris) 1970;128:161-90.
Parker V, Nobler MS, Pedley TA, Sackeim HA. A unilateral, prolonged,
nonconvulsive seizure in a patient treated with bilateral ECT. J ECT 2001;17:292-3.
Paquier PF, van Dongen HR, Loonen CB. The Landau-Kleffner syndrome or
'acquired aphasia with convulsive disorder': long term follow-up of six
children and a review of the recent literature. Arch Neurol 1992;49:354-9.
Pascual-Castroviejo I, Martin VL, Bermejo AM, Higueras AP. Is cerebral
arteritis the cause of the Landau-Kleffner syndrome? Four cases in childhood
with angiographic study. Can J Neurolog Sci 1992;19:46-52.
Patry G, Lyagoubi S, Tassinari A. Subclinical "electrical status
epilepticus" induced by sleep in children. Arch Neurol 1971;24:242-52.
Penfield W, Jasper HH. Epilepsy and functional anatomy of the human brain.
Boston: Little Brown, 1954.
Perri Di R, Messina C. Studio elettroclinico di due casi di "stato
di male temporale". In: Angeleri V, Canger R, editors. Progressi
in epileptologia. Bull Italian League against Epilepsy 1978;22-3:203-8.
Petit J, Roubertie A, Inoue Y, Genton P. Non-convulsive status in the
ring chromosome 20 syndrome: a video illustration of 3 cases. Epileptic
Disord 1999;1:237-41.
Petsche H, Rappelsberger P, Lapins R, Vollmer R. Rhythmicity in seizure
patterns-topographical aspects. In: Speckmann EJ, Caspers H, editors.
Origin of cerebral field potentials. Stuttgart: Thieme, 1979:60-79.
Picornell Darder J, Conde M, Carbonell J. Etat de mal post-traumatique
à symptomatologie uniquement psychique. Rev EEG Neurophysiol 1978;8:341-4.
Pontius AA. Motiveless firesetting: implicating partial limbic seizure
kindling by revived memories of fires in "Limbic Psychotic Trigger
Reaction". Percept Mot Skills 1999;88:970-82.
Porter RJ, Penry JK. Petit mal status. In: Delgado-Escueta AV, Wasterlain
CG, Treiman DM, Porter RJ, editors. Status epilepticus. Advances in neurology.
New York: Raven Press, 1983:34:61-7.
Prichard JC. A treatise on diseases of the nervous system. London: Underwood,
1822.
Primavera A, Audenino D, Cocito L. Ifosfamide encephalopathy and nonconvulsive
status epilepticus. Can J Neurol Sci 2002;29:180-3.
Privitera MD, Hoffman M, Moore JL, Jester D. EEG detection of non tonic-clonic
status epilepticus in patients with altered consciousness. Epilepsy Res
1994;18:155-66.
Privitera MD, Strawsburg RH. Electroencephalographic monitoring in the
emergency department. Emerg Med Clin North Am 1994;12:1089-100.
Rabending G, Fischer W. Epileptic psychosis and nonconvulsive status
epilepticus with ictal bradycardia and asystole. Psychiatr Neurol Med
Psychol (Leipz) 1986;38:184-8.
Rao KM, Gangadhar BN, Janakiramaiah N. Nonconvulsive status epilepticus
after the ninth electroconvulsive therapy. Convuls Ther 1993;9:128-9.
Rey M, Papy JJ. A critical confusion state of frontal origin in elderly
subjects: difficult diagnosis. Rev Electroencephalogr Neurophysiol Clin
1987;17:377-85.
Rogawski MA, Gryder D, Castaneda D, Yonekawa W, Banks MK, Lia H. GluR5
kainate receptors, seizures, and the amygdala. Ann N Y Acad Sci 2003;985:150-62.
Roger J, Lob H, Tassinari CA. Status epilepticus. In: Magnus O, Lorentz
de Haas AM, editors. The epilepsies. Handbook of clinical neurology. Vol
15. Amsterdam: North Holland Publishing Company, 1974:145-88.
Roger J, Travet C, Bureau M, et al. Etats de mal partiel chez l'enfant
et l'adolescent. In: Angeleri V, Canger R, editors. Progressi in epileptologia.
Bull Italian League against Epilepsy 1978;22-3:195-201.
Rossi PG, Parmeggiani A, Posar A, Scaduto MC, Chiodo S, Vatti G: Landau-Kleffner
syndrome (LKS): long-term follow-up and links with electrical status epilepticus
during sleep (ESES). Brain Dev 1999;21:90-8.
Roze E, Oubary P, Chédru F. Status-like recurrent pilomotor seizures:
case report and review of the literature. Neurol Neurosurg Psychiatry
2000;68:647-9.
Ruegg SJ, Dichter MA. Diagnosis and treatment of nonconvulsive status
epilepticus in an intensive care unit setting. Curr Treat Options Neurol
2003;5:93-110.
Sailer U, Bohr K, Bauer G. Epileptic prodromal manifestations and episodic
affective symptoms: nonspecific complaints or non-convulsive status epilepticus?
Nervenarzt 1991;62:240-3.
Salanopoulou AS, Bojko A, Lado F, Moshe SL. The spectrum of neuropsychiatric
abnormalities associated with electrical status epilepticus in sleep.
Brain Dev 2000;22:279-95.
Salas-Puig J, Suarez-Moro R, Mateos V. Status epilepticus. Neurologia
1996;11(Suppl 4):108-21.
Schapel G, Chadwick D. Tiagabine and non-convulsive status epilepticus.
Seizure 1996;5:153-6.
Schiffter R, Straschill M. Aura continua musicalis - bericht über einen
krankheitsfall mit sensorischem status epilepticus. Nervenarzt 1977;48:321-35.
Scott JS, Masland RL. Occurrence of "continuous symptoms" in
epilepsy patients. Neurology 1953;3:297-301.
Seegers U, Potschka H, Loscher W. Transient increase of P-glycoprotein
expression in endothelium and parenchyma of limbic brain regions in the
kainate model of temporal lobe epilepsy. Epilepsy Res 2002;51:257-68.
Shafrir Y, Prensky AL. Acquired epileptiform opercular syndrome: a second
case report, review of the literature, and comparison to the Landau-Kleffner
syndrome. Epilepsia 1995;36:1050-7.
Shimosaka S, So YT, Simon RP. Distribution of HSP72 induction and neuronal
death following limbic seizures. Neurosci Lett 1992;138:202-6.
Shinawi M, Shahar E. Neurodevelopmental delay associated with nonconvulsive
status epilepticus in a toddler. J Child Neurol 2001;16:215-7.
Shinnar S, Maytal J, Krasnoff L, Moshe SL. Recurrent status epilepticus
in children. Ann Neurol 1992;31:598-604.
Shorvon S. Status epilepticus. Cambridge: University Press, 1994:382.
Shoumaker RD, Bennet DR, Bray PF, Curless RG. Clinical and EEG manifestations
of an unusual aphasic syndrome in children. Neurology 1974;24:10-6.
Siegel AM, Williamson PD, Roberts DW, Thadani VM, Darcey TM. Localized
pain associated with seizures originating in the parietal lobe. Epilepsia
1999;40:845-55.
Simon R. Physiological consequences of status epilepticus. Epilepsia
1985;26(Suppl):558-66.
Sloviter RS. "Epileptic" brain damage in rats induced by sustained
electrical stimulation of the perforant paths. I. Acute electrophysiological
and light microscopic studies. Brain Res Bull 1983;10:675-97.
Smith DB, Treiman DM, Trimble MR, editors. Neurobehavioral problems in
epilepsy. Advances in neurology. Vol. 55. New York: Raven Press, 1991.
So EL, Ruggles KH, Ahmann PA, Trudeau SK, Weatherford KJ, Trennery MR.
Clinical significance and outcome of subclinical status epilepticus in
adults. J Epilepsy 1995,8:11-5.
Sobel DF, Aung M, Otsubo H, Smith MC. Magnetoencephalography in children
with Landau-Kleffner syndrome and acquired epileptic aphasia. Am J Neuroradiol
2000;21:301-7.
Solomons K, Holliday S, Illing M. Non-convulsive status epilepticus complicating
electroconvulsive therapy. Int J Geriatr Psychiatry 1998;13:731-4.
Sowa MV, Pituck S. Prolonged spontaneous complex visual hallucinations
and illusions as ictal phenomena. Epilepsia 1989;30:524-6.
Staufenberg EF, Brown SW. Some issues in non-convulsive status epilepticus
in children and adolescents with learning difficulties. Seizure 1994;3:95-105.
Stecker MM, Kramer TH, Raps EC, O'Meeghan R, Dulaney E, Skaar DJ. Treatment
of refractory status epilepticus with propofol: clinical and pharmacokinetic
findings. Epilepsia 1998;39(1):18-26.
Stodieck SR, Wieser HG. Autonomic phenomena in temporal lobe epilepsy.
J Autonom Nerv Syst 1986;(Suppl):611-21.
Stores G, Zaiwalla Z, Styles E, Hoshika A. Non-convulsive status epilepticus.
Arch Dis Child 1995;73:106-11.
Suopanki J, Lintunen M, Lahtinen H, et al. Status epilepticus induces
changes in the expression and localization of endogenous palmitoyl-protein
thioesterase 1. Neurobiol Dis 2002;10:247-57.
Tassinari CA, Bureau M, Dalla Bernardina B, Roger J. Epilepsy with continuous
spikes and waves during slow sleep-otherwise described as ESES (epilepsy
with electrical status epilepticus during slow sleep). In: Roger J, Bureau
M, Dravet C, Dreifuss FE, Perret A, Wolf P, editors. Epileptic syndromes
in infancy, childhood and adolescence. 2nd ed. London: John Libbey, 1992:245-56.
Tassinari CA, Rubboli G, Volpi L, et al. Encephalopathy with electrical
status epilepticus during slow sleep or ESES syndrome including the acquired
aphasia. Clin Neurophysiol 2000;111(Suppl)2:94-102.
Taylor J. Selected writings of John Hughlings Jackson. On epilepsy and
epileptiform convulsions. Vol 1. London: Hodder and Stoughton, 1931.
Thomas P. Status epilepticus with confusional symptomatology [French].
Neurophysiol Clin 2000;30:147-54.
Thomas P, Beaumanoir A, Genton P, Dolisi C, Chatel M. " De novo
" absence status of late onset: report of 11 cases. Neurology 1992;42:104-10.
Tomson T, Lindbom U, Nilsson B, et al. Serum prolactin during status
epilepticus. J Neurol Neurosurg Psychiatry 1989;52:1435-7.
Towne AR, Garnett LK, Waterhouse EJ, Morton LD, DeLorenzo RJ. The use
of topiramate in refractory status epilepticus. Neurology 2003;60:332-4.
Treiman DM. Status epilepticus. Baillieres Clin Neurol 1996;5:821-39.
Treiman DM, Delgado-Escueta AV. Complex partial status epilepticus. In:
Delgado-Escueta AV, Wasterlain CG, Treimann DM, Porter RJ, editors. Status
epilepticus. Advances in neurology. New York: Raven Press, 1983:34:15-35.
Treiman DM, Myers PD, Walton NY, et al. A comparison of four treatments
for generalized convulsive status epilepticus. N Engl J Med 1998;339:792-8.
Trimble MR, Bolwig TG, editors. The temporal lobes and the limbic system.
Petersfield, UK: Wrightson Biomed Publ, 1992.
Trinka E, Dilitz E, Unterberger I, et al Non convulsive status epilepticus
after replacement of valproate with lamotrigine. J Neurol 2002;249:1417-22.
Trousseau A. Clinique médicale de L'Hôtel Dieu de Paris, tome premiere.
Paris: Baillière et fils, 1868.
Tyrode Y. L'état de mal temporal. Approche clinique et électroencéphalographique.
Concours Med 1976;98:266-79.
Ueki Y, Terada K, Otsuka A, Kanda M, Akiguchi I. A case of non-convulsive
status epilepticus worsened Wernicke's aphasia reversely [Japanese]. Rinsho
Shinkeigaku 2000;40:339-43.
Van Buren JM. The abdominal aura: a study of abdominal sensations occurring
in epilepsy and produced by depth stimulation. Electroenceph Clin Neurophysiol
1963;15:1-19.
Varon D, Pritchard PB 3rd, Wagner MT, Topping K. Transient Kluver-Bucy
syndrome following complex partial status epilepticus. Epilepsy Behav
2003;4:348-51.
Veggiotti P, Beccaria F, Guerrini R, Capovilla G, Lanzi G. Continuous
spike-and-wave activity during slow-wave sleep; syndrome or EEG pattern?
Epilepsia 1999;40:1593-601.
Vernea JJ. Partial status epilepticus with speech arrest. Proc Aust Assoc
Neurol 1974;11:224-8.
Vespa PM, Nenov V, Nuwer MR. Continuous EEG monitoring in the intensive
care unit: early findings in clinical efficacy. J Clin Neurophysiol 1999;16:1-13.
Walker MC. Diagnosis and treatment of nonconvulsive status epilepticus.
CNS Drugs 2001;15:931-9.
Wasterlain CG, Liu H, Mazarati AM, et al. Self-sustaining status epilepticus:
a condition maintained by potentiation of glutamate receptors and by plastic
changes in substance P and other peptide neuromodulators. Epilepsia 2000;41(Suppl
6):S134-43.
Waterhouse EJ, Vaughan JK, Barnes PY, et al. Synergistic effect of status
epilepticus and ischemic brain injury on mortality. Epilepsy Res 1998;29:175-83.
Waxman SG, Geschwind N. The interictal behavioral syndrome of temporal
lobe epilepsy. Arch Gen Psychiatry 1975;32:1580-6.
Weber B, Lehnertz K, Elger CE, Wieser HG. Neuronal complexity loss in
interictal EEG recorded with foramen ovale electrodes predicts side of
primary epileptogenic area in temporal lobe epilepsy. A replication study.
Epilepsia 1998;39:922-7.
Weil AA. Depressive reactions associated with temporal lobe uncinate
seizures. J Nerv Ment Dis 1955;121:505-10.
Weil AA. Ictal depression and anxiety in temporal lobe disorders. Am
J Psychiatry 1956;113:149-57.
Wells CR, Labor DR, Solomon GE. Aphasia as the sole manifestation of
simple partial status epilepticus. Epilepsia 1992;33:84-7.
Whitty CM. Causalgic pain as an epileptic aura. Epilepsia 1953;2:37-41.
Wieser HG. "Psychische Anfälle" und deren stereoelektroenzephalographisches
Korrelat. Z EEG-EMG 1979;10:197-206.
Wieser HG. Temporal lobe of psychomotor status epilepticus: a case report.
Electroencephalogr Clin Neurophysiol 1980;48:558-72.
Wieser HG. Stereoelektroenzephalographisches korrelat motorischer anfälle.
Z EEG-EMG 1981;12:1-13.
Wieser HG. Zur Frage der lokalisatorischen bedeutung epileptischer halluzinationen.
In: Karbowski K, editor. Halluzinationen bei epilepsien und ihre differentialdiagnose.
Bern: Huber Verlag, 1982:67-92.
Wieser HG. Depth recorded limbic seizures and psychopathology. Neurosci
Biobehav Rev 1983;7:427-40.
Wieser HG. Spontane und evozierte spitzentätigkeit im tiefen- und oberflächen-EEG.
EEG-Labor 1988;10:8-30.
Wieser HG. Pre-ictal EEG findings. Epilepsia 1989;30:664.
Wieser HG. Ictal manifestation of temporal lobe seizures. In: Smith DB,
Treiman D, Trimble M, editors. Neurobehavioral problems in epilepsy. Advances
in neurology. Vol 55. New York: Raven Press, 1991:301-15.
Wieser HG. Stereoelectroencephalography and foramen ovale electrode recording.
In: Niedermeyer E, Lopes da Silva F, editors. Electroencephalography.
3rd ed. Baltimore: Williams and Wilkins, 1993:679-93.
Wieser HG. Simple partial status epilepticus. In: Engel J Jr, Pedley
TA, editors. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven
Publishers, 1997:709-23.
Wieser HG. Electrophysiological aspects of forced normalization. In:
Trimble MR, Bettina Schmitz, editors. Forced normalization and alternative
psychoses of epilepsy. Petersfield, UK: Wrightson Biomedical Publ, 1998:95-119.
Wieser HG. EEG, the language of the brain, and its neurochemical souffleuse.
Schweiz Arch Neurol Psych 1999;150:62-71.
Wieser HG. Temporal lobe epilepsies. In: Meinardi H, editor. The Epilepsies,
part II. Handbook of clinical neurology. Vol 73. Amsterdam: Elsevier,
2000:53-96.
Wieser HG, Hailemariam S, Regard M, Landis T. Unilateral limbic epileptic
status activity: stereo EEG, behavioral, and cognitive data. Epilepsia
1985;26:19-29.
Wieser HG, Hajek M. Epilepsia partialis continua des Kindesalters. In:
Fröscher W, Vasella F, editors. Die Epilepsien Berlin: W de Gruyter, 1994:273-80.
Wieser HG, Landis T. Is the "interictal behaviour syndrome of temporal
lobe epilepsy" really an "interictal" phenomenon? Neurol
Psychiatr 1983;6:70-8.
Wieser HG, Siegfried J, Bernoulli C. Corrélations stéréo-electroencéphalographiques
des manifestations psychiatriques dans l'épilepsie. Med Hyg 1981;39:1920-8.
Wieser HG, Williamson PD. Ictal semiology. In: Engel J Jr, editor. Surgical
treatment of the epilepsies. 2nd ed. New York: Raven Press, 1993:161-71.
Wilkinson HA. Epileptic pain. An uncommon manifestation with localizing
value. Neurology 1973;25:518-20.
Williamson PD. Complex partial status epilepticus. In: Engel J Jr, Pedley
TA, editors. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven
Publishers, 1997:681-99.
Wolf P. Zur klinik und psychopathologie des status psychomotoricus. Nervenarzt
1970;41:603-10.
Worster-Drought C. An unusual form of acquired aphasia in children. Dev
Med Child Neurol 1971;13:563-71.
Yakovlev PI. Motility, behavior and the brain. Stereodynamic organization
and neural coordinates of behavior. J Nerv Ment Dis 1948;107:313-35.
Yoshimura K. A case of nonconvulsive status epilepticus associated with
focal cortical dysplasia. Brain Dev 2003;25:207-10.
Yoshino A. Psychotropic agents may induce de novo nonconvulsive status
epilepticus. Nihon Shinkei Seishin Yakurigaku Zasshi 2000;20:1-10.
Young GB, Blume WT. Painful epileptic seizures. Brain 1983;106:537-54.
Young GB, Jordan KG. Do nonconvulsive seizures damage the brain? - Yes.
Arch Neurol 1998;55:117-9.
Young GB, Kreeft JH, McLachlan RS, Demelo J. EEG and clinical association
with mortality in comatose patients in general intensive care unit. J
Clin Neurophysiol 1999;16:354-60.
ILAE
ILAE Copyright Notice
Abbreviations
cIV-MDZ:continuous intravenous midazolam
NMDA:N-methyl-D-aspartate
NCSE:nonconvulsive status epilepticus
PLED:periodic lateralized epileptiform discharges
PPT1:palmitoyl-protein thioesterase 1
Synonyms
Complex partial status epilepticus
Continuous status of partial seizures with complex symptomatology
Electroencephalographic status epilepticus with subtle clinical signs
Epileptic twilight states with productive-psychotic signs and symptoms
Limbic status epilepticus
Temporal lobe status epilepticus
Subtopics
Acquired epileptiform opercular syndrome
Aura continua
Continuous spikes and waves during slow wave sleep
Epilepsy with continuous spike waves during sleep
Epileptic behavioral disturbances
Epileptic psychosis
Subclinical status
Major keyword descriptors
continuous forms
discontinuous forms
epileptic twilight state
limbic system
nonconvulsive status epilepticus
psychomotor status epilepticus
seizure discharges
status epilepticus
temporal lobe
Minor keyword descriptors
alteration in mental status
behavioral change
cognitive abnormalities
depth recording
EEG seizure pattern
ictal activity
ongoing discharge
Age of presentation
06-12 years
13-18 years
19-44 years
45-64 years
65+ years
Age of typical presentation
06-12 years
13-18 years
19-44 years
45-64 years
Permuted topic, synonyms,
variants
Limbic status epilepticus (psychomotor status)
Limbic status epilepticus
staus epilepticus, Limbic
psychomotor status
epilepticus, Complex partial status
partial status epilepticus, Complex
status epilepticus, Complex partial
seizures with complex symptomatology, Continuous status
status epilepticus with subtle clinical signs, Electroencephalographic
epilepticus with subtle clinical signs, Electroencephalographic status
twilight states with productive-psychotic signs and symptoms, Epileptic
productive-psychotic signs and symptoms, Epileptic twilight states with
psychotic signs and symptoms, Epileptic twilight states with productive
Temporal lobe status epilepticus
opercular syndrome, Acquired epileptiform
epileptiform opercular syndrome, Acquired
continua, Aura
sleep, Continuous spikes and waves during slow wave
continuous spike waves during sleep, Epilepsy with
disturbance, Epileptic behavioral
behavioral disturbance, Epileptic
psychosis, Epileptic
status, Subclinical
Related topics
Benign epilepsy of infancy with partial seizures
Benign myoclonic epilepsy in infancy
Electrical status epilepticus during slow sleep
HIV-associated dementia
Lennox-Gastaut syndrome
Migrating partial epilepsy in infancy
West syndrome
Differential diagnosis
focal neurologic deficits
Wernicke aphasia
neuropsychiatric manifestations
confusion
learning difficulties
absence status